Hereditary Persistence of α-Fetoprotein Is Due to Both Proximal and Distal Hepatocyte Nuclear Factor-1 Site Mutations

Gastroenterology

Volumn 126, Issue 1 SUPPL. 1, 2004, Pages 308-317

  Alj, Youssef ^a   Georgiakaki, Maria ^a   Savouret, Jean François ^a   Mal, Frédéric ^b   Attali, Pierre ^a   Pelletier, Gilles ^a   Fourré, Catherine ^a   Milgrom, Edwin ^a   Buffet, Catherine ^a   Guiochon Mantel, Anne ^a   Perlemuter, Gabriel ^c  

^a BICÊTRE HOSPITAL   (France)

^b INSTITUT MUTUALISTE MONTSOURIS   (France)

^c HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; NUCLEAR FACTOR I;

ADULT; ARTICLE; ASSAY; AUTOSOMAL DOMINANT DISORDER; BINDING AFFINITY; CASE REPORT; CLINICAL FEATURE; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA BINDING; FAMILY STUDY; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HEREDITARY PERSISTENCE OF ALPHA FETOPROTEIN; HUMAN; HUMAN CELL; MALE; NUCLEIC ACID BASE SUBSTITUTION; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION;

EID: 9144245599     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2003.10.073     Document Type: Article

References (72)

1. Gitlin D, Perricelli A, Gitlin G. Synthesis of AFP by liver, yolk and intestinal tract of the human conceptus. Cancer Res 1972;32: 970-972.
2. Belayew A, Tilghman SM. Genetic analysis of alpha-fetoprotein synthesis in mice. Mol Cell Biol 1982;2:1427-1435.
3. Chen H, Egan JO, Chiu JF. Regulation and activities of alpha-fetoprotein. Crit Rev Eukaryot Gene Expr 1997;7:11-41.
4. Wu JT, Book L, Sudar K. Serum alpha fetoprotein (AFP) levels in normal infants. Pediatr Res 1981;15:50-52.
5. Tilghman SM, Belayew A. Transcriptional control of the murine albumin/alpha-fetoprotein locus during development. Proc Natl Acad Sci U S A 1982;79:5254-5257.
6. Lazarevich NL. Molecular mechanisms of alpha-fetoprotein gene expression. Biochemistry (Mosc) 2000;65:117-133.
7. Jin DK, Vacher J, Feuerman MH. Alpha-Fetoprotein gene sequences mediating Afr2 regulation during liver regeneration. Proc Natl Acad Sci U S A 1998;95:8767-8772.
8. Taketa K. Alpha-fetoprotein: reevaluation in hepatology. Hepatology 1990;12:1420-1432.
9. Sato Y, Nakata K, Kato Y, Shima M, Ishii N, Koji T, Taketa K, Endo Y, Nagataki S. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N Engl J Med 1993;328:1802-1806.
10. Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamoto S. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 1994;19: 61-66.
11. Nomura F, Ohnishi K, Tanabe Y. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients. Cancer 1989;64:1700-1707.
12. Kondo F, Wada K, Nagato Y, Nakajima T, Kondo Y, Hirooka N, Ebara M, Ohto M, Okuda K. Biopsy diagnosis of well-differentiated hepatocellular carcinoma based on new morphologic criteria. Hepatology 1989;9:751-755.
13. Brumm C, Schulze C, Charels K, Morohoshi T, Kloppel G. The significance of alpha-fetoprotein and other tumour markers in differential immunocytochemistry of primary liver tumours. Histopathology 1989;14:503-513.
14. Trevisani F, D'Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P, Domenicali M, De Notariis S, Roda E, Bernardi M. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 2001;34:570-575.
15. Sherman M. Alphafetoprotein: an obituary. J Hepatol 2001;34: 603-605.
16. Cooke NE, David EV. Serum vitamin D-binding protein is a third member of the albumin and alpha fetoprotein gene family. J Clin Invest 1985;76:2420-2424.
17. Yang F, Brune JL, Naylor SL, Cupples RL, Naberhaus KH, Bowman BH. Human group-specific component (Gc) is a member of the albumin family. Proc Natl Acad Sci U S A 1985;82:7994-7998.
18. Belanger L, Roy S, Allard D. New albumin gene 3′ adjacent to the alpha 1-fetoprotein locus. J Biol Chem 1994;269:5481-5484.
19. Nishio H, Heiskanen M, Palotie A, Belanger L, Dugaiczyk A. Tandem arrangement of the human serum albumin multigene family in the sub-centromeric region of 4q: evolution and chromosomal direction of transcription. J Mol Biol 1996;259:113-119.
20. Courtois G, Baumhueter S, Crabtree GR. Purified hepatocyte nuclear factor 1 interacts with a family of hepatocyte-specific promoters. Proc Natl Acad Sci U S A 1988;85:7937-7941.
21. Feuerman MH, Godbout R, Ingram RS, Tilghman SM. Tissue-specific transcription of the mouse alpha-fetoprotein gene promoter is dependent on HNF-1. Mol Cell Biol 1989;9:4204-4212.
22. Wright CV. Vertebrate homeobox genes. Curr Opin Cell Biol 1991; 3:976-982.
23. Tronche F, Ringeisen F, Blumenfeld M, Yaniv M, Pontoglio M. Analysis of the distribution of binding sites for a tissue-specific transcription factor in the vertebrate genome. J Mol Biol 1997; 266:231-245.
24. Ferguson-Smith MA, May HM, O'Hare E, Aitken DA. Hereditary persistence of alphafetoprotein: a new autosomal dominant trait identified in an antenatal screening programme for spina bifida. J Med Genet 1983;20:458.
25. Gumucio DL, Rood KL, Gray TA, Riordan MF, Sartor CI, Collins FS. Nuclear proteins that bind the human gamma-globin gene promoter: alterations in binding produced by point mutations associated with hereditary persistence of fetal hemoglobin. Mol Cell Biol 1988;8:5310-5322.
26. Mantovani R, Malgaretti N, Nicolis S, Ronchi A, Giglioni B, Ottolenghi S. The effects of HPFH mutations in the human gamma-globin promoter on binding of ubiquitous and erythroid specific nuclear factors. Nucleic Acids Res 1988;16:7783-7797.
27. Forget BG. Molecular basis of hereditary persistence of fetal hemoglobin. Ann N Y Acad Sci 1998;850:38-44.
28. Adinolfi A, Adinolfi M, Lessof MH. Alpha-feto-protein during development and in disease. J Med Genet 1975;12:138-151.
29. Bellini C, Bonacci W, Paridu E, Serra G. Serum alpha-fetoprotein in newborns. Clin Chem 1998;44:2548-2550.
30. McVey JH, Michaelides K, Hansen LP, Ferguson-Smith M, Tilghman S, Krumlauf R, Tuddenham EG. A G→A substitution in an HNF I binding site in the human alpha-fetoprotein gene is associated with hereditary persistence of alpha-fetoprotein (HPAFP). Hum Mol Genet 1993;2:379-384.
31. Staples J. Alphafetoprotein, cancer, and benign conditions. Lancet 1986;2:1277.
32. Greenberg F, Rose E, Alpert E. Hereditary persistence of alpha-fetoprotein. Gastroenterology 1990;98:1083-1085.
33. Feng YZ, Liu J, Zhou XR. Hereditary persistence of alpha-fetoprotein. Zhonghua Zhong Liu Za Zhi 1994;16:54-55.
34. Mal F, Girard P, Gayet B. Congenital high increase of serum alpha-fetoprotein: case of a family. Gastroenterol Clin Biol 1997; 21:903.
35. Schefer H, Mattmann S, Joss RA. Hereditary persistence of alpha-fetoprotein. Case report and review of the literature. Ann Oncol 1998;9:667-672.
36. Cochran PK, Chauvenet AR, Hart PS, de Graaf SS, Cushing B, Kroovand L, Wofford MM. Hereditary persistence of alpha-fetoprotein in a child with testicular germ cell tumor. Med Pediatr Oncol 1999;32:436-437.
37. Flechon A, Droz JP. Hereditary persistence of alpha-fetoprotein in testis disease. J Urol 2001;2004:165.
38. Platini C. Hereditary persistence of alpha-fetoprotein: report of a case. Rev Med Interne 2002;23:182-188.
39. Tronche F, Yaniv M. HNF1, a homeoprotein member of the hepatic transcription regulatory network. Bioessays 1992;14:579-587.
40. Streeper RS, Eaton EM, Ebert DH, Chapman SC, Svitek CA, O'Brien RM. Hepatocyte nuclear factor-1 acts as an accessory factor to enhance the inhibitory action of insulin on mouse glucose-6-phosphatase gene transcription. Proc Natl Acad Sci U S A 1998;95:9208-9213.
41. Savouret JF, Bailly A, Misrahi M, Rauch C, Redeuilh G, Chauchereau A, Milgrom E. Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene. EMBO J 1991;10:1875-1883.
42. Rouet P, Raguenez G, Tronche F, Yaniv M, N'Guyen C, Salier JP. A potent enhancer made of clustered liver-specific elements in the transcription control sequences of human alpha 1-microglobulin/bikunin gene. J Biol Chem 1992;267:20765-20773.
43. Mendel DB, Hansen LP, Graves MK, Conley PB, Crabtree GR. HNF-1 alpha and HNF-1 beta (vHNF-1) share dimerization and homeo domains, but not activation domains, and form heterodimers in vitro. Genes Dev 1991;5:1042-1056.
44. Bach I, Yaniv M. More potent transcriptional activators or a transdominant inhibitor of the HNF1 homeoprotein family are generated by alternative RNA processing. EMBO J 1993;12: 4229-4242.
45. Blesa JR, Giner-Duran R, Vidal J, Lacalle ML, Catalan I, Bixquert M, Igual L, Hernandez-Yago J. Report of hereditary persistence of alpha-fetoprotein in a Spanish family: molecular basis and clinical concerns. J Hepatol 2003;38:541-544.
46. Chouard T, Blumenfeld M, Bach I, Vandekerckhove J, Cereghini S, Yaniv M. A distal dimerization domain is essential for DNA-binding by the atypical HNF1 homeodomain. Nucleic Acids Res 1990;18:5853-5863.
47. Nicosia A, Monaci P, Tomei L, De Francesco R, Nuzzo M, Stunnenberg H, Cortese R. A myosin-like dimerization helix and an extra-large homeodomain are essential elements of the tripartite DNA binding structure of LFB1. Cell 1990;61:1225-1236.
48. Toniatti C, Demartis A, Monaci P, Nicosia A, Ciliberto G. Synergistic trans-activation of the human C-reactive protein promoter by transcription factor HNF-1 binding at two distinct sites. EMBO J 1990;9:4467-4475.
49. Spek CA, Greengard JS, Griffin JH, Bertina RM, Reitsma PH. Two mutations in the promoter region of the human protein C gene both cause type I protein C deficiency by disruption of two HNF-3 binding sites. J Biol Chem 1995;270:24216-24221.
50. Thomassin H, Hamel D, Bernier D, Guertin M, Belanger L. Molecular cloning of two C/EBP-related proteins that bind to the promoter and the enhancer of the alpha 1-fetoprotein gene. Further analysis of C/EBP beta and C/EBP gamma. Nucleic Acids Res 1992;20:3091-3098.
51. Takiguchi M. The C/EBP family of transcription factors in the liver and other organs. Int J Exp Pathol 1998;79:369-391.
52. Mantovani R. The molecular biology of the CCAAT-binding factor NF-γ. Gene 1999;239:15-27.
53. Bois-Joyeux B, Danan JL. Members of the CAAT/enhancer-binding protein, hepatocyte nuclear factor-1 and nuclear factor-1 families can differentially modulate the activities of the rat alpha-fetoprotein promoter and enhancer. Biochem J 1994;301:49-55.
54. Bois-Joyeux B, Thomassin H, Richard F, Ikonomova R, Denissenko M, Danan JL. Several transcription factors participate in the functioning of the alpha-fetoprotein gene promoter. Bull Cancer 1995;82:541-550.
55. Song YH, Ray K, Liebhaber SA, Cooke NE. Vitamin D-binding protein gene transcription is regulated by the relative abundance of hepatocyte nuclear factors 1alpha and 1beta. J Biol Chem 1998;273:28408-28418.
56. Camper SA, Godbout R, Tilghman SM. The developmental regulation of albumin and alpha-fetoprotein gene expression. Prog Nucleic Acid Res Mol Biol 1989;36:131-143.
57. Superti-Furga G, Barberis A, Schaffner G, Busslinger M. The -117 mutation in Greek HPFH affects the binding of three nuclear factors to the CCAAT region of the gamma-globin gene. EMBO J 1988;7:3099-3107.
58. Katsube T, Fukumaki Y. A role for the distal CCAAT box of the gamma-globin gene in Hb switching. J Biochem (Tokyo) 1995; 117:68-76.
59. Ronchi A, Berry M, Raguz S, Imam A, Yannoutsos N, Ottolenghi S, Grosveld F, Dillon N. Role of the duplicated CCAAT box region in gamma-globin gene regulation and hereditary persistence of fetal haemoglobin. EMBO J 1996;15:143-149.
60. Zertal-Zidani S, Merghoub T, Ducrocq R, Gerard N, Satta D, Krishnamoorthy R. A novel C→A transversion within the distal CCAAT motif of the Ggamma-globin gene in the Algerian Ggammabeta+-hereditary persistence of fetal hemoglobin. Hemoglobin 1999;23:159-169.
61. Lin Y, Jin DK, Vacher J, Feuerman MH. Sequence requirements for alpha-fetoprotein gene expression during liver regeneration. Cell Growth Differ 1995;6:1549-1558.
62. Camper SA, Tilghman SM. Postnatal repression of the alpha-fetoprotein gene is enhancer independent. Genes Dev 1989;3: 537-546.
63. Peyton DK, Huang MC, Giglia MA, Hughes NK, Spear BT. The alpha-fetoprotein promoter is the target of Afr1-mediated postnatal repression. Genomics 2000;63:173-180.
64. Peyton DK, Ramesh T, Spear BT. Position-dependent activity of alpha-fetoprotein enhancer element III in the adult liver is due to negative regulation. Proc Natl Acad Sci U S A 2000;97:10890-10894.
65. Zhang DE, Ge X, Rabek JP, Papaconstantinou J. Functional analysis of the trans-acting factor binding sites of the mouse alpha-fetoprotein proximal promoter by site-directed mutagenesis. J Biol Chem 1991;266:21179-21185.
66. Soutoglou E, Papafotiou G, Katrakili N, Talianidis I. Transcriptional activation by hepatocyte nuclear factor-1 requires synergism between multiple coactivator proteins. J Biol Chem 2000; 275:12515-12520.
67. Soutoglou E, Katrakili N, Talianidis I. Acetylation regulates transcription factor activity at multiple levels. Mol Cell 2000;5:745-751.
68. Soutoglou E, Viollet B, Vaxillaire M, Yaniv M, Pontoglio M, Talianidis I. Transcription factor-dependent regulation of CBP and P/CAF histone acetyltransferase activity. EMBO J 2001;20:1984-1992.
69. Parrizas M, Maestro MA, Boj SF, Paniagua A, Casamitjana R, Gomis R, Rivera F, Ferrer J. Hepatic nuclear factor 1-alpha directs nucleosomal hyperacetylation to its tissue-specific transcriptional targets. Mol Cell Biol 2001;21:3234-3243.
70. Igarashi K, Aoyagi Y, Ohkoshi S, Yokota T, Mori S, Suda T, Kamimura T, Asakura H. Sequence analysis of the proximal promoter region of the human alpha-fetoprotein gene in hepatocellular carcinoma. Cancer Lett 1994;76:93-99.
71. Spear BT. Alpha-fetoprotein gene regulation: lessons from transgenic mice. Semin Cancer Biol 1999;9:109-116.
72. Tokoro K, Chiba Y, Ohtani T, Abe H, Yagishita S. Pineal ganglioglioma in a patient with familial basal ganglia calcification and elevated serum alpha-fetoprotein: case report. Neurosurgery 1993;33:506-511.